BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24280069)

  • 1. Curcumin glucuronides: assessing the proliferative activity against human cell lines.
    Pal A; Sung B; Bhanu Prasad BA; Schuber PT; Prasad S; Aggarwal BB; Bornmann WG
    Bioorg Med Chem; 2014 Jan; 22(1):435-9. PubMed ID: 24280069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Biological Evaluations of Monocarbonyl Curcumin Inspired Pyrazole Analogues as Potential Anti-Colon Cancer Agent.
    Min Z; Zhu Y; Hong X; Yu Z; Ye M; Yuan Q; Hu X
    Drug Des Devel Ther; 2020; 14():2517-2534. PubMed ID: 32636614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
    Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma.
    Qiu C; Hu Y; Wu K; Yang K; Wang N; Ma Y; Zhu H; Zhang Y; Zhou Y; Chen C; Li S; Fu L; Zhang X; Liu Z
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5971-5976. PubMed ID: 27825763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
    Li Q; Chen J; Luo S; Xu J; Huang Q; Liu T
    Eur J Med Chem; 2015 Mar; 93():461-9. PubMed ID: 25728027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and anticancer evaluation of long-chain alkoxylated mono-carbonyl analogues of curcumin.
    Weng Q; Fu L; Chen G; Hui J; Song J; Feng J; Shi D; Cai Y; Ji J; Liang G
    Eur J Med Chem; 2015 Oct; 103():44-55. PubMed ID: 26318057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel curcumin analogs targeting TNF-induced NF-kappaB activation and proliferation in human leukemic KBM-5 cells.
    Zambre AP; Kulkarni VM; Padhye S; Sandur SK; Aggarwal BB
    Bioorg Med Chem; 2006 Nov; 14(21):7196-204. PubMed ID: 16843665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression.
    Nakamae I; Morimoto T; Shima H; Shionyu M; Fujiki H; Yoneda-Kato N; Yokoyama T; Kanaya S; Kakiuchi K; Shirai T; Meiyanto E; Kato JY
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31717651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of dimethylaminomethyl-substituted curcumin derivatives/analogues: potent antitumor and antioxidant activity, improved stability and aqueous solubility compared with curcumin.
    Fang X; Fang L; Gou S; Cheng L
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1297-301. PubMed ID: 23357628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.
    Chen QH; Yu K; Zhang X; Chen G; Hoover A; Leon F; Wang R; Subrahmanyam N; Addo Mekuria E; Harinantenaina Rakotondraibe L
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4553-6. PubMed ID: 26341135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGFβ-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.
    Kunihiro AG; Brickey JA; Frye JB; Luis PB; Schneider C; Funk JL
    J Nutr Biochem; 2019 Jan; 63():150-156. PubMed ID: 30393127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
    Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
    Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides.
    Lal J; Gupta SK; Thavaselvam D; Agarwal DD
    Eur J Med Chem; 2013 Jun; 64():579-88. PubMed ID: 23685942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of curcumin-related compounds for anticancer activity.
    Wei X; Du ZY; Zheng X; Cui XX; Conney AH; Zhang K
    Eur J Med Chem; 2012 Jul; 53():235-45. PubMed ID: 22551677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
    Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
    Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcuminoids form reactive glucuronides in vitro.
    Pfeiffer E; Hoehle SI; Walch SG; Riess A; Sólyom AM; Metzler M
    J Agric Food Chem; 2007 Jan; 55(2):538-44. PubMed ID: 17227090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One Pot Green Synthesis of Doxorubicin and Curcumin Loaded Magnetic Nanoparticles and Cytotoxicity Studies.
    Ak G; Karakayalı T; Cin AN; Özel B; Şanlıer ŞH
    Anticancer Agents Med Chem; 2021; 21(18):2563-2571. PubMed ID: 33438561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitors.
    Zhang W; Bai H; Han L; Zhang H; Xu B; Cui J; Wang X; Ge Z; Li R
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2459-2464. PubMed ID: 29886021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, Characterization and In Vitro Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents.
    Arjomandi OK; Almasi S; Hosseinzadeh L; Kavoosi M; Adibi H
    Anticancer Agents Med Chem; 2021; 21(10):1309-1322. PubMed ID: 33006540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.